Zenflow Procedure
Benign Prostatic Hyperplasia (BPH)
Clinical EvaluationActive
Key Facts
About Zenflow
Zenflow is a clinical-stage medical device company pioneering a new treatment for benign prostatic hyperplasia (BPH). The company's procedure is designed to be gentle, effective, and fast-recovering, addressing patient frustrations with the side effects of drugs and the discomfort of current minimally invasive therapies. With a leadership team boasting deep experience in medical device development, regulatory affairs, and commercialization, Zenflow is advancing its technology through clinical evaluation. The company targets a massive and growing market of men over 50, aiming to capture significant share by offering a superior patient experience.
View full company profileTherapeutic Areas
Other Benign Prostatic Hyperplasia (BPH) Drugs
| Drug | Company | Phase |
|---|---|---|
| Prolieve Thermodilatation System | Medifocus | Marketed |
| Optilume BPH Catheter System | Laborie | Commercial |
| RoLEP™ (Robotic-assisted HoLEP) | Andromeda Surgical | Unknown |
| TULSA-PRO® | Profound Medical | Commercial |
| Fexapotide Triflutate (NX-1207) | Nymox Pharmaceutical | Phase 3 |